Literature DB >> 20628865

[Imaging diagnostics of the prostate].

D J Dinter1, A M Weidner, F Wenz, A E Pelzer, M S Michel, S O Schoenberg.   

Abstract

Prostate cancer is the most common malignancy of men with approximately 32,000 new cases of prostate cancer in Germany and approximately 11,000 men who would die of the disease each year. For early diagnosis of prostate cancer PSA testing is used, whereas at present screening cannot be recommended due to the lack of confirmed medical and economic benefits. Regarding the imaging modalities, ultrasound of the prostate, currently performed in combination with elastography and histoscanning, magnetic resonance imaging of the prostate in combination with endorectal coils and positron emission tomography combined with computed tomography (PET-CT) are the methods of choice. Using these methods benign prostatitis can be differentiated from prostate cancer and staging of the tumor can be accomplished. On the other hand using these imaging methods it is possible to define the dominant intraprostatic lesion with different sensitivities and specificities, which is important for minimally invasive therapeutic strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20628865     DOI: 10.1007/s00120-010-2338-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  31 in total

1.  Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging.

Authors:  Aliya Qayyum; Fergus V Coakley; Ying Lu; Jeffrey D Olpin; Louis Wu; Benjamin M Yeh; Peter R Carroll; John Kurhanewicz
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

2.  [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.

Authors:  Ludwig Rinnab; Joerg Simon; Richard E Hautmann; M V Cronauer; Kathrin Hohl; Andreas K Buck; Sven N Reske; Felix M Mottaghy
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

3.  11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.

Authors:  G Martorana; R Schiavina; B Corti; M Farsad; E Salizzoni; E Brunocilla; A Bertaccini; F Manferrari; P Castellucci; S Fanti; R Canini; W F Grigioni; A D'Errico Grigioni
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

4.  Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

Authors:  Igle J de Jong; Jan Pruim; Philip H Elsinga; Willem Vaalburg; Han J Mensink
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

5.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.

Authors:  Chan Kyo Kim; Byung Kwan Park; Bohyun Kim
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

6.  Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?

Authors:  Martin Heinisch; Albert Dirisamer; Wolfgang Loidl; Franz Stoiber; Bernhard Gruy; Silke Haim; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

7.  MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.

Authors:  Sophie F Riches; Geoffrey S Payne; Veronica A Morgan; Samir Sandhu; Cyril Fisher; Michael Germuska; David J Collins; Alan Thompson; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

8.  Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

Authors:  Giampiero Giovacchini; Maria Picchio; Elisa Coradeschi; Valentino Bettinardi; Luigi Gianolli; Vincenzo Scattoni; Cesare Cozzarini; Nadia Di Muzio; Patrizio Rigatti; Ferruccio Fazio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-15       Impact factor: 9.236

Review 9.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

10.  Prostate: techniques, results, and potential applications of color Doppler US scanning.

Authors:  M D Rifkin; G S Sudakoff; A A Alexander
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

View more
  4 in total

Review 1.  [Multiparametric MRI, elastography, contrastenhanced TRUS. Are there indications with reliable diagnostic advantages before prostate biopsy?].

Authors:  A Hegele; L Skrobek; R Hofmann; P Olbert
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  A new 5-grading score in the diagnosis of prostate cancer with real-time elastography.

Authors:  Guang Xu; Lijing Feng; Minghua Yao; Jian Wu; Lehang Guo; Xudong Yao; Lixia Zhao; Huixiong Xu; Rong Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  [Multiparametric prostate MRI for follow-up monitoring after radiation therapy].

Authors:  A M Weidner; D J Dinter; M Bohrer; M Sertdemir; D Hausmann; F Wenz; S O Schoenberg
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

4.  Incremental learning with SVM for multimodal classification of prostatic adenocarcinoma.

Authors:  José Fernando García Molina; Lei Zheng; Metin Sertdemir; Dietmar J Dinter; Stefan Schönberg; Matthias Rädle
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.